- Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group
-
Trillsch F, Mahner S, Czogalla B, Rottmann M, Chekerov R, Braicu EI, Oskay-Öczelik G, Wimberger P, Richter R, Sehouli J
- KMID: 2526394
- J Gynecol Oncol.
- 2021 May;32(3):e37.
- doi: 10.3802/jgo.2021.32.e37
Objective: Patients with platinum-resistant ovarian cancer (PROC) have a high need for reliable prognostic markers. Since significance of primary platinum resistance (PPR) versus secondary platinum resistance (SPR) was identified for... -
- CITED
-
- Close
- SHARE
-
- Close
- Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer
-
Woopen H, Pietzner K, Richter R, Fotopoulou C, Joens T, Braicu EI, Mellstedt , Mahner S, Lindhofer , Darb-Esfahani S, Denkert C, Sehouli J
- KMID: 2130103
- J Gynecol Oncol.
- 2014 Jul;25(3):221-228.
- doi: 10.3802/jgo.2014.25.3.221
OBJECTIVE: Epithelial cell adhesion molecule (EpCAM) has experienced a renaissance lately as a binding site for targeted therapy as well as a prognostic marker in epithelial malignancies. Aim of this... -
- CITED
-
- Close
- SHARE
-
- Close
